Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

SELL
$12.21 - $23.36 $36,288 - $69,425
-2,972 Reduced 71.86%
1,164 $26,000
Q3 2023

Oct 27, 2023

BUY
$11.84 - $18.65 $48,970 - $77,136
4,136 New
4,136 $62,000
Q2 2022

Jul 25, 2022

SELL
$0.99 - $2.11 $21,167 - $45,113
-21,381 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$1.68 - $3.92 $451 - $1,054
-269 Reduced 1.24%
21,381 $43,000
Q4 2021

Jan 28, 2022

BUY
$3.36 - $14.64 $72,744 - $316,956
21,650 New
21,650 $82,000

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $66.4M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.